PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NVO vs. AAPL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NVO and AAPL is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

NVO vs. AAPL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novo Nordisk A/S (NVO) and Apple Inc (AAPL). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
-39.95%
2.76%
NVO
AAPL

Key characteristics

Sharpe Ratio

NVO:

-0.70

AAPL:

1.15

Sortino Ratio

NVO:

-0.80

AAPL:

1.72

Omega Ratio

NVO:

0.89

AAPL:

1.22

Calmar Ratio

NVO:

-0.55

AAPL:

1.60

Martin Ratio

NVO:

-1.48

AAPL:

4.06

Ulcer Index

NVO:

17.13%

AAPL:

6.53%

Daily Std Dev

NVO:

36.27%

AAPL:

22.99%

Max Drawdown

NVO:

-71.31%

AAPL:

-81.80%

Current Drawdown

NVO:

-46.24%

AAPL:

-11.21%

Fundamentals

Market Cap

NVO:

$352.92B

AAPL:

$3.46T

EPS

NVO:

$2.93

AAPL:

$6.07

PE Ratio

NVO:

26.86

AAPL:

37.89

PEG Ratio

NVO:

1.28

AAPL:

2.08

Total Revenue (TTM)

NVO:

$204.72B

AAPL:

$271.46B

Gross Profit (TTM)

NVO:

$173.22B

AAPL:

$125.83B

EBITDA (TTM)

NVO:

$108.42B

AAPL:

$91.44B

Returns By Period

The year-to-date returns for both investments are quite close, with NVO having a -8.52% return and AAPL slightly higher at -8.16%. Over the past 10 years, NVO has underperformed AAPL with an annualized return of 15.65%, while AAPL has yielded a comparatively higher 25.22% annualized return.


NVO

YTD

-8.52%

1M

-25.74%

6M

-39.95%

1Y

-26.03%

5Y*

22.75%

10Y*

15.65%

AAPL

YTD

-8.16%

1M

-7.93%

6M

2.76%

1Y

20.64%

5Y*

24.45%

10Y*

25.22%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NVO vs. AAPL — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVO
The Risk-Adjusted Performance Rank of NVO is 1212
Overall Rank
The Sharpe Ratio Rank of NVO is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of NVO is 1414
Sortino Ratio Rank
The Omega Ratio Rank of NVO is 1313
Omega Ratio Rank
The Calmar Ratio Rank of NVO is 1414
Calmar Ratio Rank
The Martin Ratio Rank of NVO is 66
Martin Ratio Rank

AAPL
The Risk-Adjusted Performance Rank of AAPL is 7979
Overall Rank
The Sharpe Ratio Rank of AAPL is 8181
Sharpe Ratio Rank
The Sortino Ratio Rank of AAPL is 7575
Sortino Ratio Rank
The Omega Ratio Rank of AAPL is 7373
Omega Ratio Rank
The Calmar Ratio Rank of AAPL is 8787
Calmar Ratio Rank
The Martin Ratio Rank of AAPL is 7777
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NVO vs. AAPL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Apple Inc (AAPL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for NVO, currently valued at -0.70, compared to the broader market-2.000.002.004.00-0.701.15
The chart of Sortino ratio for NVO, currently valued at -0.80, compared to the broader market-4.00-2.000.002.004.00-0.801.72
The chart of Omega ratio for NVO, currently valued at 0.89, compared to the broader market0.501.001.502.000.891.22
The chart of Calmar ratio for NVO, currently valued at -0.55, compared to the broader market0.002.004.006.00-0.551.60
The chart of Martin ratio for NVO, currently valued at -1.48, compared to the broader market-10.000.0010.0020.0030.00-1.484.06
NVO
AAPL

The current NVO Sharpe Ratio is -0.70, which is lower than the AAPL Sharpe Ratio of 1.15. The chart below compares the historical Sharpe Ratios of NVO and AAPL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00AugustSeptemberOctoberNovemberDecember2025
-0.70
1.15
NVO
AAPL

Dividends

NVO vs. AAPL - Dividend Comparison

NVO's dividend yield for the trailing twelve months is around 1.83%, more than AAPL's 0.43% yield.


TTM20242023202220212020201920182017201620152014
NVO
Novo Nordisk A/S
1.83%1.68%1.00%1.20%1.34%1.86%2.14%2.47%2.12%3.93%1.31%1.96%
AAPL
Apple Inc
0.43%0.40%0.49%0.70%0.49%0.61%1.04%1.79%1.45%1.93%1.93%1.67%

Drawdowns

NVO vs. AAPL - Drawdown Comparison

The maximum NVO drawdown since its inception was -71.31%, smaller than the maximum AAPL drawdown of -81.80%. Use the drawdown chart below to compare losses from any high point for NVO and AAPL. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-46.24%
-11.21%
NVO
AAPL

Volatility

NVO vs. AAPL - Volatility Comparison

Novo Nordisk A/S (NVO) has a higher volatility of 21.75% compared to Apple Inc (AAPL) at 7.18%. This indicates that NVO's price experiences larger fluctuations and is considered to be riskier than AAPL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
21.75%
7.18%
NVO
AAPL

Financials

NVO vs. AAPL - Financials Comparison

This section allows you to compare key financial metrics between Novo Nordisk A/S and Apple Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab